About Bavarian Nordic A/S (BVNKF) — Dividend Analysis 2026
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Is BVNKF a good dividend investment in 2026?
BVNKF offers a 6.73% forward yield with a 50% payout ratio. Strand Safety Score: 85/100 (Very Safe). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
BVNKF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your BVNKF portfolio grows to $10.94M vs $10.25M without reinvestment. This is the compound interest effect in action.
BVNKF dividend growth history & forecast
BVNKF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 6.73%.
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 BVNKF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BVNKF.
Gross yield
6.73%
Tax rate
15.00%
After-tax yield
5.72%
Real yield (−CPI)
2.92%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
6.73%
3.93%
$673 / yr
🇺🇸 US Taxable (15%) ✓
15%
5.72%
2.92%
$572 / yr
🇺🇸 US Taxable (20%)
20%
5.38%
2.58%
$538 / yr
🇬🇧 UK ISA
0%
6.73%
3.93%
$673 / yr
🇬🇧 UK Taxable
8.75%
6.14%
3.34%
$614 / yr
🇨🇦 TFSA
0%
6.73%
3.93%
$673 / yr
🇨🇦 CA Taxable
25%
5.05%
2.25%
$505 / yr
🇦🇺 Super (pension)
15%
5.72%
2.92%
$572 / yr
🇦🇺 AU Taxable
30%
4.71%
1.91%
$471 / yr
🇩🇪 DE Taxable
26.375%
4.95%
2.15%
$495 / yr
🇫🇷 FR Taxable
30%
4.71%
1.91%
$471 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BVNKF Income Goal & Break-Even
Dividend Break-Even
18yr
Years for dividends to fully repay your BVNKF investment of $29.71/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$6.0K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$3.5K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in BVNKF for:
Shares needed
14,118
Capital required
$419,446
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BVNKF Dividend Payment Schedule
BVNKF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 BVNKF vs Healthcare Benchmarks
How BVNKF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+3.93% vs sectorBetter
BVNKF
6.73%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
BVNKF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
BVNKF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BVNKF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BVNKF Insider Activity
No recent SEC filings reported in the last 90 days.
📅
Next Earnings Report: 2026-05-13(in 43 days)
🔬
Financial Health Scores
Altman Z-Score
6.82
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
8/9
✅ Strong fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BVNKF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →